After Hours Summary: FBIO +47% on NEJM article on glioblastoma case study.... NVDA -1.1% continues pull back in after hours following today's Citron report/Andrew Left Fast Money appearanceAfter Hours Gainers:
- FBIO +46.7% (MB-101 for the treatment of glioblastoma was highlighted in the New England Journal of Medicine)
- KATE +0.8% (continued strength)
- PHH +0.5% and NRZ +0.4% (PHH Corp to sell entire portfolio of mortgage servicing rights to New Residential Investment-excluding the Ginnie Mae)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance:
- VII -8.1% (thinly traded and ticking lower - filed to delay Form 10-K, disclosed preliminary FY16 results)
Companies trading lower in after hours in reaction to news:
- ALR -1.2% (ticking lower; Alere provides update on Arriva Medical billing privileges for Diabetes Testing Supplies; Arriva has filed an appeal - decision expected within three month)
- NVDA -1.1% (continues pull back in after hours -- Citron released report intraday and Andrew Left appeared on Fast Money after the close)